换一批
换一批Conversion of a cyclooxygenase (CO) inhibitor into a 5-lipoxygenase (LO) inhibitor: a general route to novel orally active anti-inflammatory and anti-allergy drugs.
第一作者：
A F,Kreft
第一单位：
Wyeth-Ayerst Research, Princeton, NJ.
作者：
主题词
投药, 口服(Administration, Oral);动物(Animals);消炎药(Anti-Inflammatory Agents);消炎药, 非甾类(Anti-Inflammatory Agents, Non-Steroidal);环加氧酶抑制药(Cyclooxygenase Inhibitors);类花生酸类(Eicosanoids);豚鼠(Guinea Pigs);超敏反应(Hypersensitivity);白三烯类(Leukotrienes);脂氧合酶抑制剂(Lipoxygenase Inhibitors);肌收缩(Muscle Contraction);萘醋酸类(Naphthaleneacetic Acids);喹啉类(Quinolines);SRS-A(SRS-A);气管(Trachea)
PMID
1822830
发布时间
2010-11-18
- 浏览15
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
